| Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study A Bhangu, AO Ademuyiwa, ML Aguilera, P Alexander, SW Al-Saqqa, ... The Lancet Infectious Diseases 18 (5), 516-525, 2018 | 409 | 2018 |
| Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open … R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ... The Lancet Neurology 17 (5), 405-415, 2018 | 326 | 2018 |
| Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial D Cadavid, M Mellion, R Hupperts, KR Edwards, PA Calabresi, J Drulović, ... The Lancet Neurology 18 (9), 845-856, 2019 | 156 | 2019 |
| The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations G Pardo, DE Jones Journal of neurology 264 (12), 2351-2374, 2017 | 118 | 2017 |
| Assessment of postural balance in multiple sclerosis C Fjeldstad, G Pardo, C Frederiksen, D Bemben, M Bemben International Journal of MS Care 11 (1), 1-5, 2009 | 103 | 2009 |
| IFN-β treatment requires B cells for efficacy in neuroautoimmunity RD Schubert, Y Hu, G Kumar, S Szeto, P Abraham, J Winderl, ... The Journal of Immunology 194 (5), 2110-2116, 2015 | 99 | 2015 |
| Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis M Kaufman, G Pardo, H Rossman, MT Sweetser, F Forrestal, P Duda Journal of the neurological sciences 341 (1-2), 22-27, 2014 | 91 | 2014 |
| Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results G Giovannoni, O Barbarash, F Casset-Semanaz, J King, L Metz, G Pardo, ... Multiple Sclerosis Journal 15 (2), 219-228, 2009 | 90 | 2009 |
| Decreased postural balance in multiple sclerosis patients with low disability C Fjeldstad, G Pardo, D Bemben, M Bemben International Journal of Rehabilitation Research 34 (1), 53-58, 2011 | 83 | 2011 |
| Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study DH Miller, RJ Fox, JT Phillips, M Hutchinson, E Havrdova, M Kita, ... Neurology 84 (11), 1145-1152, 2015 | 81 | 2015 |
| Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high … C Fjeldstad, M Bemben, G Pardo Journal of Clinical Neuroscience 18 (11), 1469-1472, 2011 | 77 | 2011 |
| Retinal changes associated with tamoxifen treatment for breast cancer R Tang, J Shields, J Schiffman, H Li, D Locher, J Hampton, T Prager, ... Eye 11 (3), 295-297, 1997 | 76 | 1997 |
| Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model NR Jog, MT McClain, LD Heinlen, T Gross, R Towner, JM Guthridge, ... Journal of autoimmunity 106, 102332, 2020 | 61 | 2020 |
| Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24-and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase … G Giovannoni, O Barbarash, F Casset-Semanaz, A Jaber, J King, L Metz, ... Clinical therapeutics 29 (6), 1128-1145, 2007 | 52 | 2007 |
| Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223 B Steingo, Y Al Malik, AD Bass, R Berkovich, M Carraro, Ó Fernández, ... Journal of Neurology 267, 3343-3353, 2020 | 42 | 2020 |
| Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome DT Okuda, O Kantarci, C Lebrun‐Frénay, MP Sormani, CJ Azevedo, ... Annals of neurology 93 (3), 604-614, 2023 | 41 | 2023 |
| Headache and its management in patients with multiple sclerosis F Husain, G Pardo, M Rabadi Current Treatment Options in Neurology 20, 1-13, 2018 | 35 | 2018 |
| Telerehabilitation in multiple sclerosis: results of a randomized feasibility and efficacy pilot study C Fjeldstad-Pardo, A Thiessen, G Pardo International journal of telerehabilitation 10 (2), 55, 2018 | 35 | 2018 |
| A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis H Zwibel, G Pardo, S Smith, D Denney, MK Oleen-Burkey Journal of neurology 258, 402-411, 2011 | 35 | 2011 |
| Nutrition and optic nerve disease C Woon, RA Tang, G Pardo Seminars in ophthalmology 10 (3), 195-202, 1995 | 32 | 1995 |
